Friday, 17 Aug 2018

You are here

Dr. Paul Emery ACR17 - Microarray Pathways in Baricitinib vs Adalimumab Treated RA

For more on this presentation https://buff.ly/2zkxALQ

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

The RheumNow Week in Review – 3 March...

03 Mar 2017

Dr. Richard Furie - Anifrolumabs...

29 Aug 2016

Dr. Len Calabrese: Herpes Zoster

08 Nov 2017

Dr. Ben Nowell at EULAR 2018 - Barriers...

14 Jun 2018

The RheumNow Week in Review – 21 April...

21 Apr 2017

4 Contraindications to TNF Inhibitor Use

03 Oct 2016

Dr. Olga Petryna - Canakinumab in...

15 Jun 2017

Dr Jack Cush: Stills and Auto-...

08 Nov 2017

The RheumNow Week in Review - 16 March...

16 Mar 2018

Dr. Janet Pope at EULAR 2018 on...

20 Jun 2018

Dr. Len Calabrese: New IL-6 therapies,...

14 Nov 2016

Dr. Mark Werner - EULAR Symposia on...

14 Aug 2016